Nuclear Factor-κB Activity in β-Cells Is Required for Glucose-Stimulated Insulin Secretion
- Address correspondence and reprint requests to Helena Edlund the Umeå Center for Molecular Medicine, University of Umeå, S-901 87 Umeå, Sweden. E-mail: helena.edlund{at}ucmm.umu.se
Abstract
Glucose-stimulated insulin secretion (GSIS) in pancreatic β-cells depends on coordinated glucose uptake, oxidative metabolism, and Ca2+-triggered insulin exocytosis. Impaired GSIS is a hallmark of type 2 diabetes. However, at present we know very little about the molecular mechanisms that induce and maintain the expression of genes required for GSIS in β-cells. The transcription factor nuclear factor-κB (NF-κB) is activated by an increase in intracellular Ca2+ in β-cells. Here, we show that attenuation of NF-κB activation in β-cells generates mice with impaired GSIS, and that the β-cells show perturbed expression of genes required for glucose uptake, oxidative metabolism, and insulin exocytosis. Thus, NF-κB appears to be part of a positive regulatory circuit that maintains GSIS in pancreatic β-cells.
- FBS, fetal bovine serum
- FGFR1c, fibroblast growth factor receptor 1c
- GSIS, glucose-stimulated insulin secretion
- HNF-1α, hepatocyte nuclear factor-1α
- IκB, inhibitor κB
- IPF, insulin promoter factor
- KATP channel, ATP-sensitive K+ channel
- MAP, mitogen-activated protein
- MAPK, MAP kinase
- MEK, MAP/ERK (extracellular signal-related kinase) kinase
- NF-κB, nuclear factor-κB
- PDTC, pyrollidine dithiocarbamate
- PDX1, pancreatic duodenal homeobox 1
- SUR1, sulfonylurea receptor 1
- TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling
- UCP, uncoupling protein
Footnotes
-
H.E. is a cofounder and shareholder of Betagenon, a biotechnology company.
-
- Accepted September 21, 2004.
- Received June 23, 2004.
- DIABETES














